Reply to: Does acamprosate really produce its anti-relapse effects via calcium? No support from the PREDICT study in human alcoholics

Neuropsychopharmacology

Volumn 41, Issue 3, 2016, Pages 661-662

  Spanagel, Rainer ^a   Vengeliene, Valentina ^a   Kiefer, Falk ^a  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALCOHOL; CALCIUM; PLACEBO; DRUGS USED IN THE TREATMENT OF ADDICTION; TAURINE;

ALCOHOL CONSUMPTION; ALCOHOLISM; CALCIUM BLOOD LEVEL; DRUG TREATMENT FAILURE; LETTER; MICROINJECTION; PRIORITY JOURNAL; STRIA TERMINALIS; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; ANIMAL; HUMAN; MALE; METABOLISM;

ALCOHOL DETERRENTS; ALCOHOLISM; ANIMALS; CALCIUM; HUMANS; MALE; TAURINE;

EID: 84953911755     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.263     Document Type: Letter

References (5)

1. Boismare F, Daoust M, Moore N, Saligaut C, Lhuintre JP, Chretien P et al (1984). A homotaurine derivative reduces the voluntary intake of ethanol by rats: Are cerebral GABA receptors involved? Pharmacol Biochem Behav 21: 787-789.
2. Mann K, Hoffmann S, Pawlak CR (2015). Does acamprosate really produce its anti-relapse effects via calcium? No support from the PREDICT study in human alcoholics. Neuropsychopharmacology.
3. Mann K, Lemenager T, Hoffmann S, Reinhard I, Hermann D, Batra A et al (2013). Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addict Biol 18: 937-946.
4. Rösner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M (2010). Acamprosate for alcoholdependence. Cochrane Database Syst Rev (9): CD004332.
5. Spanagel R, Vengeliene V, Jandeleit B, Fischer WN, Grindstaff K, Zhang X et al (2014). Acamprosate produces its anti-relapse effects via calcium. Neuropsychopharmacology 39: 783-791.